Industry Roundup: Waters Posts Strong Q2 Financial Results

Waters Corporation reported second-quarter 2026 financial results that exceeded its own guidance, with executives pointing to a market recovery that is now extending beyond the customer segments that had been driving growth to date, a signal worth watching for labs that had been holding off on capital purchases.

Instrument and Consumables Growth in the Analytical Sciences Division

For analytical scientists, the most relevant figures come from the company's Analytical Sciences Division (ASD), the core chromatography and mass spectrometry business, comprising the legacy Waters Division minus its Clinical Business Unit. ASD delivered reported revenue of $669 million for the quarter, up from $627 million in the same period last year, and the division posted 8% instrument growth alongside double-digit growth in chemistry consumables.¹

Within ASD, growth was led by low-double-digit gains in both the Pharma and Academic & Government (A&G) end markets, on a constant-currency basis. Company leadership characterized this as evidence that the broader market recovery has moved into a new phase, one that is no longer confined to a narrow set of customer segments, but instead reaching previously lagging areas of the market.

Company-wide, organic revenue reached $828 million for the quarter, an increase of 7% as reported and 9% in constant currency, compared to $771 million a year earlier.

Context: A Company Still Integrating Major Acquisitions

The quarter's results also reflect Waters' ongoing integration of the Biosciences and Diagnostic Solutions businesses acquired from Becton, Dickinson and Company (BD), which contributed $817 million in revenue for the quarter, exceeding the company's guidance by $15 million and representing 4% growth on a comparable basis. Those businesses, now organized as the Biosciences Division and Advanced Diagnostics Division, are reported separately from the Analytical Sciences Division but factor into the combined company's overall performance and outlook.

CEO Udit Batra noted that the newly acquired businesses grew at a mid-single-digit rate in their first full quarter under Waters ownership, and attributed part of this acceleration to a "180-day growth revitalization plan" aimed at improving commercial execution and operations.¹

The integration is also visible in the company's Generally Accepted Accounting Principles (GAAP) results: Waters reported a GAAP diluted loss per share of $1.39 for the quarter, driven by acquisition-related purchase accounting charges, including amortization of acquired intangibles and inventory step-up costs; these are figures that reflect deal mechanics rather than underlying operating performance. Adjusted Earnings Per Share (EPS), which strips out those charges, grew 3% year-over-year to $3.05.

Materials Sciences Division Growth

The Materials Sciences Division (formerly TA Division), which serves thermal analysis and rheology applications relevant to materials characterization labs, posted reported revenue of $87 million (up from $82 million a year earlier), modest but steady growth consistent with the broader trend across the company's instrument businesses.

What This Means Going Forward

Waters raised all components of its full-year 2026 guidance following the quarter's results. The company now expects full-year organic constant-currency revenue growth of 7% to 9%, up from prior guidance, along with adjusted EPS in the range of $14.45 to $14.65, representing 10% to 12% year-over-year growth.

For laboratories and researchers tracking instrument and consumables spending trends as a proxy for sector health, the raised guidance and the specific mention of A&G market strength may be of particular interest, given that academic and government funding environments have been a source of uncertainty in recent budget cycles. Whether the double-digit growth in chemistry consumables reflects genuine demand recovery versus restocking after a slower period is a distinction the company's Q3 results, expected later this year, should help clarify.

Reference

1. Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results. Waters Corporation website.https://ir.waters.com/News--Events/newsroom/news-details/2026/Waters-Corporation-NYSE-WAT-Reports-Second-Quarter-2026-Financial-Results/default.aspx (accessed 2026-08-04)